CAR T-Cell Therapy Continues to Revolutionize Hematologic Cancer Treatment
The number of FDA-approved CAR T-cell therapies has increased from 3 to 5 drugs in the past year. This new treatment regimen looks promising to continue to evolve in the years to come, offering hope for patients with relapsing hematologic…